MAGEA3 and breast carcinoma: MAGEA12 is reported to promote the expression of MAGEA2 and MAGEA3; The higher expression of MAGEA3 is reported to be accompanied by up-regulated expression and activity of ERα, which further leads tamoxifen resistance in breast cancer.